Related Experiment Video

Updated: Apr 11, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

[Dyslipidemia and stroke in patients with chronic kidney disease]

Petar Kes, Vanja Bašić-Kes, Vesna Furic-Cunko

    Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
    |May 28, 2015
    PubMed

    Insights

    Chronic kidney disease (CKD) causes dyslipidemia, increasing cardiovascular risks. This review examines CKD-related lipid changes and treatments, focusing on hypolipidemic drugs to reduce stroke risk in kidney patients.

    Area of Science:

    • Nephrology
    • Cardiology
    • Metabolic Disorders

    Background:

    • Altered lipid and lipoprotein metabolism is a hallmark of chronic kidney disease (CKD).
    • Dyslipidemia persists across all stages of kidney disease, including dialysis and transplantation.
    • These lipid abnormalities accelerate atherosclerosis, leading to high rates of cardiovascular disease and stroke.

    Purpose of the Study:

    • To review the pathogenesis of dyslipidemia in chronic kidney disease.
    • To analyze lipid abnormalities in predialysis, hemodialysis, and peritoneal dialysis patients.
    • To report on the efficacy of hypolipidemic drugs in reducing stroke morbidity and mortality in CKD patients.

    Main Methods:

    • Literature review of studies on lipid metabolism in CKD.
    • Analysis of lipid profiles in predialysis, hemodialysis, and peritoneal dialysis populations.
    • Examination of clinical trial data on hypolipidemic agents and cardiovascular outcomes.

    Main Results:

    • CKD-induced dyslipidemia involves complex changes in lipoprotein structure and function.
    • Dyslipidemia is a significant contributor to cardiovascular disease and stroke in CKD patients.
    • Hypolipidemic drug studies provide insights into managing stroke risk.

    Conclusions:

    • CKD-associated dyslipidemia is a complex multifactorial condition.
    • Effective management of lipid abnormalities is crucial for reducing cardiovascular events in CKD.
    • Targeted therapies, including hypolipidemic drugs, are essential for improving outcomes in kidney disease patients.

    More Related Videos

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    15.2K
    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    22.5K

    Related Concept Videos

    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    1.0K
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    645
    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    1.2K
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
    655
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    1.9K
    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
    515